Training for mental health professionals in responding to experienced and anticipated mental health-related discrimination (READ-MH): protocol for an international multisite feasibility study.
Discrimination
Health advocacy
Health professionals
Mental health care
Objective structured Clinical examination
Stigma
Training
Journal
Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536
Informations de publication
Date de publication:
13 Dec 2022
13 Dec 2022
Historique:
received:
18
03
2022
accepted:
13
10
2022
entrez:
13
12
2022
pubmed:
14
12
2022
medline:
14
12
2022
Statut:
epublish
Résumé
Mental health and other health professionals working in mental health care may contribute to the experiences of stigma and discrimination among mental health service users but can also help reduce the impact of stigma on service users. However, few studies of interventions to equip such professionals to be anti-stigma agents took place in high-income countries. This study assesses the feasibility, potential effectiveness and costs of Responding to Experienced and Anticipated Discrimination training for health professionals working in mental health care (READ-MH) across low- and middle-income countries (LMICs). This is an uncontrolled pre-post mixed methods feasibility study of READ-MH training at seven sites across five LMICs (China, Ethiopia, India, Nepal and Tunisia). knowledge based on course content, attitudes to working to address the impact of stigma on service users and skills in responding constructively to service users' reports of discrimination. The training draws upon the evidence bases for stigma reduction, health advocacy and medical education and is tailored to sites through situational analyses. Its content, delivery methods and intensity were agreed upon through a consensus exercise with site research teams. READ-MH will be delivered to health professionals working in mental health care immediately after baseline data collection; outcome measures will be collected post-training and 3 months post-baseline, followed by qualitative data collection analysed using a combined deductive and inductive approach. Fidelity will be rated during the delivery of READ-MH, and data on training costs will be collected. Quantitative data will be assessed using generalised linear mixed models. Qualitative data will be evaluated by thematic analysis to identify feedback about the training methods and content, including the implementability of the knowledge and skills learned. Pooled and site-specific training costs per trainee and per session will be reported. The training development used a participatory and contextualised approach. Evaluation design strengths include the diversity of settings, the use of mixed methods, the use of a skills-based measure and the knowledge and attitude measures aligned to the target population and training. Limitations are the uncertain generalisability of skills performance to routine care and the impact of COVID-19 restrictions at several sites limiting qualitative data collection for situational analyses.
Sections du résumé
BACKGROUND
BACKGROUND
Mental health and other health professionals working in mental health care may contribute to the experiences of stigma and discrimination among mental health service users but can also help reduce the impact of stigma on service users. However, few studies of interventions to equip such professionals to be anti-stigma agents took place in high-income countries. This study assesses the feasibility, potential effectiveness and costs of Responding to Experienced and Anticipated Discrimination training for health professionals working in mental health care (READ-MH) across low- and middle-income countries (LMICs).
METHODS
METHODS
This is an uncontrolled pre-post mixed methods feasibility study of READ-MH training at seven sites across five LMICs (China, Ethiopia, India, Nepal and Tunisia).
OUTCOME MEASURES
METHODS
knowledge based on course content, attitudes to working to address the impact of stigma on service users and skills in responding constructively to service users' reports of discrimination. The training draws upon the evidence bases for stigma reduction, health advocacy and medical education and is tailored to sites through situational analyses. Its content, delivery methods and intensity were agreed upon through a consensus exercise with site research teams. READ-MH will be delivered to health professionals working in mental health care immediately after baseline data collection; outcome measures will be collected post-training and 3 months post-baseline, followed by qualitative data collection analysed using a combined deductive and inductive approach. Fidelity will be rated during the delivery of READ-MH, and data on training costs will be collected. Quantitative data will be assessed using generalised linear mixed models. Qualitative data will be evaluated by thematic analysis to identify feedback about the training methods and content, including the implementability of the knowledge and skills learned. Pooled and site-specific training costs per trainee and per session will be reported.
CONCLUSIONS
CONCLUSIONS
The training development used a participatory and contextualised approach. Evaluation design strengths include the diversity of settings, the use of mixed methods, the use of a skills-based measure and the knowledge and attitude measures aligned to the target population and training. Limitations are the uncertain generalisability of skills performance to routine care and the impact of COVID-19 restrictions at several sites limiting qualitative data collection for situational analyses.
Identifiants
pubmed: 36514144
doi: 10.1186/s40814-022-01208-8
pii: 10.1186/s40814-022-01208-8
pmc: PMC9745687
doi:
Types de publication
Journal Article
Langues
eng
Pagination
257Subventions
Organisme : Medical Research Council
ID : MR/S001255/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S023224/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R023697/1
Pays : United Kingdom
Commentaires et corrections
Type : UpdateOf
Informations de copyright
© 2022. The Author(s).
Références
Br J Psychiatry. 2015 Nov;207(5):377-84
pubmed: 26527664
Br J Addict. 1987 Jul;82(7):753-9
pubmed: 3478065
Lancet Psychiatry. 2014 Nov;1(6):467-82
pubmed: 26361202
Behav Res Ther. 2015 Jun;69:11-21
pubmed: 25847276
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
J Adv Nurs. 2012 Jun;68(6):1359-68
pubmed: 21981761
Int J Soc Psychiatry. 2008 Sep;54(5):469-78
pubmed: 18786908
Aust N Z J Psychiatry. 2014 Apr;48(4):360-70
pubmed: 24253359
Psychiatr Serv. 2011 Dec;62(12):1470-6
pubmed: 22193795
Soc Psychiatry Psychiatr Epidemiol. 2022 Sep;57(9):1861-1873
pubmed: 35451604
BMC Med Educ. 2019 Jan 31;19(1):41
pubmed: 30704531
Community Pract. 2007 Sep;80(9):26-9
pubmed: 17900024
Soc Sci Med. 2020 Jun;255:112974
pubmed: 32388323
World Psychiatry. 2012 Feb;11(1):61
pubmed: 22295014
Med Teach. 2013 Sep;35(9):e1437-46
pubmed: 23968323
Psychiatr Serv. 2014 Nov 1;65(11):1360-6
pubmed: 25081996
Fortschr Neurol Psychiatr. 2014 Oct;82(10):586-92
pubmed: 25299630
Lancet. 2016 Mar 12;387(10023):1123-1132
pubmed: 26410341
Acta Psychiatr Scand. 2016 Aug;134 Suppl 446:14-22
pubmed: 27426642
Aust N Z J Psychiatry. 1999 Feb;33(1):77-83
pubmed: 10197888
Pilot Feasibility Stud. 2018 Jan 24;4:36
pubmed: 29403650
Asian J Psychiatr. 2022 Jul;73:103096
pubmed: 35430494
Psychiatry Res. 2018 Jan;259:526-531
pubmed: 29156425
Lancet. 1998 Sep 26;352(9133):1058-9
pubmed: 9759771
Eur Psychiatry. 2004 Nov;19(7):423-7
pubmed: 15504649
Int J Soc Psychiatry. 2004 Dec;50(4):319-30
pubmed: 15648745
Acad Psychiatry. 2010 Nov-Dec;34(6):424-32
pubmed: 21041465
Fam Syst Health. 2018 Jun;36(2):198-209
pubmed: 29902036
Lancet. 2007 Sep 8;370(9590):878-89
pubmed: 17804062
Community Ment Health J. 2021 Jul;57(5):985-993
pubmed: 32892303
Pilot Feasibility Stud. 2022 Jan 14;8(1):5
pubmed: 35031066
Int J Ment Health Syst. 2019 Jan 03;13:1
pubmed: 30622627
Int Rev Psychiatry. 2007 Apr;19(2):137-55
pubmed: 17464792
Int J Environ Res Public Health. 2021 Feb 22;18(4):
pubmed: 33671743
Acad Psychiatry. 2016 Apr;40(2):339-47
pubmed: 26162463
Acta Psychiatr Scand Suppl. 2006;(429):51-9
pubmed: 16445483